日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome

GPER 的缺失为 ERα 阳性子宫内膜癌患者预后不良的一个亚群提供了新的治疗靶点。

C Krakstad ,J Trovik, E Wik, I B Engelsen, H M J Werner, E Birkeland, M B Raeder, A M Øyan, I M Stefansson, K H Kalland, L A Akslen, H B Salvesen

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer

KRAS基因扩增和过表达(而非突变)与侵袭性和转移性子宫内膜癌相关。

E Birkeland ,E Wik, S Mjøs, E A Hoivik, J Trovik, H M J Werner, K Kusonmano, K Petersen, M B Raeder, F Holst, A M Øyan, K-H Kalland, L A Akslen, R Simon, C Krakstad, H B Salvesen